Swiss drugmaker Novartis said on Friday it was looking into a report that employees of its Japanese unit may have violated clinical trial protocol by handling data from a small independent study of one of its cancer drugs. Employees of Novartis Pharma K.K. (NPKK) transferred some data from research centers to a Tokyo hospital when that data should have been sent directly without first passing through Novartis hands, according to a report by Japanese broadcaster NHK that was picked up by the Wall Street Journal. “NPKK is currently investigating the allegations,” Novartis said in a statement.
Help employers find you! Check out all the jobs and post your resume.
